Mass Spectrometry & Advances in the Clinical Lab

Reminder - first MSACL 2025 deadline is this Wednesday, December 4. Submit proposals for Short Courses, Workshops, Roundtables, and Practical Training sessions. More here: https://lnkd.in/gNcE_ySB

SCIEX is a Platinum Sponsor of MSACL 2025, in support of the clinical mass spectrometry community. Join the experts implementing mass spectrometry applications in the clinical laboratory in Montréal, Canada! Learn more at www.msacl.org. SCIEX solutions for clinical mass spec: https://lnkd.in/g67dRDzr Conference Steering Committee includes Margret Thorsteinsdottir, Timothy Collier, Peggi M. Angel, Matt Crawford, Tim Garrett, Daniel Holmes, Ian Lewis, Renee Ruhaak, Deborah French, Ph.D., DABCC (CC, TC) Scientific Committee includes Nathalie Agar, Michael Chen, Shannon Haymond, Ron M.A. Heeren, Thomas Horvath, Guinevere S.M. Lageveen-Kammeijer, Ruben Luo, Kristina Schwamborn, Jody Ouweland van den, Michael Vogeser, Dajana Vuckovic, Elizabeth Want, Joshua Hayden, Jacqueline A. Hubbard, Grace van der Gugten

MSACL is coming north of the border. Monterey CA has had the pleasure of hosting this global conference on all things Mass Spectrometry as applied to the Clinical Laboratory and Clinical Research for the past few years; and now, the torch is passed to Montreal - one of the oldest cities in North America - founded in 1642. Come for the great science and experience the culture and beauty of the City. Bienvenue à Montréal! Click on the link for more information and we look forward to seeing you there: https://lnkd.in/gk2dcQb4 #MSACL2025 #LCMS4BetterCare #Montreal

⏰ 24 - 28 Feb 2025: Join us in Singapore for the first MSACL - SLING co-organized symposium! Mon - Tue: Workshops around clinical LCMS, metabolisms and quality control Wed - Fri:  Scientific presentations, posters, networking Topics this year expand from #lipids and small molecules to #metabolomics, cohort studies, nutrition, tech advances and more. 🚀 Travel awards available!  SLING - Singapore Lipidomics Incubator Mass Spectrometry & Advances in the Clinical Lab

LC-MSMS 101 for Europe and Asia time zones! 16 hours over 4 days. Register here: https://lnkd.in/ghEUsPdY#350

House Committee Tells FDA to Suspend LDT Rule. https://lnkd.in/e-96HZp7

Check out two upcoming FeMS+ Out of the Shadows Leadership Development Training sessions designed for mid-career women for valuable networking and skill building. August 16 in Melbourne, Australia the day prior to IMSC (deadline to apply July 5), and September 10 in Maryland, USA, the day prior to CASSS Mass Spec (deadline to apply July 30). https://lnkd.in/gee8nViq Anne K Bendt, Alice Ly, Carolyn Slade, MsHIM, CMM, HMCC, Maggie Tam, Erin Humphries, Nicola Gray, Sarah Hancock, Esthelle Hoedt, Vera Ignjatović, Paula Orens, Carol Lempert (She/Her), Amber Herold

Register now to join an MSACL Connect session with Philipp Lange moderated by Mari DeMarco: https://lnkd.in/g_aQ-YQt Molecularly targeted precision treatments have significant potential to improve therapy options for hard-to-treat cancers and reduce late effects in general. Genome sequencing has laid the foundation for precision medicine, yet, clinical success remains moderate. Identifying therapeutic targets at the protein and pathway level by mass spectrometry-based proteomics holds great promise. Co-organized with the CNPN Canadian National Proteomics Network . #MassSpectrometry #ClinicalChemistry #Cancer #PrecisionMedicine

We look forward to hosting Antonin Lamaziere on MSACL Connect. Register here: https://lnkd.in/gw38C4zG#348 Dr. Lamazière is a professor and hospital practitioner at Sorbonne University's Faculty of Medicine. He heads the Hospital Department of Clinical Metabolomics at Hôpital Saint Antoine (AP-HP.Sorbonne Université). His research interests lie at the interface between metabolism, nutrition and endocrine and metabolic pathologies. Through his work, he proposes translational approaches based on more fundamental pathophysiological issues, leading to the development of new diagnostic tools for use in healthcare. Recently, he and his team have highlighted the benefits of combining targeted metabolomic approaches with mathematical modeling based on machine learning and AI. The aims are both to map and better understand certain major biochemical pathways, and to envisage new endocrine semiologies to improve patient management and therapeutic follow-up. With the performance of new devices, mass spectrometry now offers real opportunities in terms of diagnosis and therapeutic follow-up, particularly in the neuro-endocrine field. Through examples of routine clinical developments carried out in our clinical department, this presentation will show how gains in sensitivity and robustness enable us to access new endocrine semiologies with simultaneous assays of endogenous/exogenous steroid profiles in serum or on DBS, assays of somatotropic axis peptides or the use of mathematical models to develop digital medical devices.  This webinar will cover the following: • Circulating steroid profiling improves management of PCOS syndrome • Clinical applications of metabolomics DBS signatures • High sensitivity 7500Qtrap enhances performances of proteomic biomarkers quantitation #MassSpectrometry #LabMedicine #Metabolomics Sponsored by SCIEX

Congratulations to the #MSACL 2024 Poster Contest Winners! View the winning posters now. Allix Coon : https://lnkd.in/gJP_NQHm Kenneth Virgin : https://lnkd.in/geDRfnTC Priscilla Yeung : https://lnkd.in/gaDqmucJ Many thanks to our poster award chairs Tim Garrett and Lauren Bishop as well as judges Dustin Bunch, Christopher Chouinard, Elizabeth Frank, Joshua Hayden, Claire E. Knezevic, Guinevere S.M. Lageveen-Kammeijer, Renee Ruhaak, Laura Sanchez, Elizabeth Want.